GlassScriptPhysician profile
Alexander Gilroy
NPI 1699344168
$4,262.41
in general payments reported to CMS, 2019-2025
20 companies · $1,046 in 2025
The $1,046 reported for 2025 was more than what 81% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $325 · 2024: $2,891 · 2025: $1,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,622 · Travel and Lodging: $1,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,621.83 |
| Travel and Lodging | $1,640.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,362.99 | 2023-2025 | Ortholoc 3di, Ortholoc 2 Lapifuse, Augment Injectable |
| Depuy Synthes Sales INC. | $492.10 | 2024-2025 | Motoband, Fibergraft Aeridyan Matrix, Vivigen Mis Delivery System |
| Paragon 28, INC. | $354.93 | 2025 | Apex 3d |
| Lifenet Health | $222.34 | 2024-2025 | Theragenesis Wound Matrix |
| Smith+Nephew, INC. | $126.17 | 2023-2025 | Collagenase Santyl, Grafix Pl, Stravix |
| Convatec INC. | $93.46 | 2023-2024 | |
| Amgen INC. | $84.29 | 2024-2025 | Krystexxa |
| Paladin Technology Solutions | $81.64 | 2023 | |
| Biocomposites INC | $66.03 | 2024 | |
| Acumed LLC | $62.80 | 2025 | Acumed |
| Vertex Pharmaceuticals Incorporated | $52.45 | 2025 | |
| Solventum Corporation | $47.90 | 2024 | V.A.C. Dermatac, Activ.A.C., V.A.C. Granufoam |
| Globus Medical, INC. | $46.09 | 2025 | Senza |
| Paratek Pharmaceuticals, INC. | $44.14 | 2024 | Nuzyra |
| Integra Lifesciences Corporation | $29.56 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.59 | 2024 | |
| Kerecis Limited | $21.51 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Polynovo North America LLC | $18.30 | 2023 | |
| Zimmer Biomet Holdings, INC. | $16.99 | 2024 | Tapestry |
| Reprise Biomedical, INC. | $16.13 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Gilroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.